Biondo Investment Advisors, LLC
Q1 2014 13F-HR Holdings
Net value change ($000)
+8,891
(3.0%)
New positions
7
Sold out positions
12
Turnover %
6.6%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q4 2013
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| URI | 5,973 | 158.4% |
| PCRX | 3,459 | 22.4% |
| ILMN | 2,246 | 27.0% |
| CORE LABORATORIES N V | 2,146 | 56.9% |
| REGADO BIOSCIENCES INC | 1,800 | NEW |
| FURIEX PHARMA INC | 1,707 | NEW |
| CHIMERIX INC | 1,454 | NEW |
| ISRG | 1,329 | 10.9% |
| EWP | 1,326 | NEW |
| ARRIS GROUP INC | 869 | NEW |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|